From its inception through the present, Mr. Cao has been the Founder, Chairman and Chief Executive Officer (CEO) of Future BioMed Corp. Mr. Cao is a consummate innovator and inventor, holding 16 patents and patents pending, and is a serial bio-entrepreneur.
Responsible for IP strategy, management of outside counsel, due diligence, validity, infringement, patentability, patent portfolio management, contract and agreement.
Tony is a medical industry executive who has over 15 years of experience in business development, healthcare management, and is an expert in improving the productivity, quality, revenue growth, and cost-effectiveness of healthcare organizations.
Member of the American Urologic Association since 1985; Member of the National Institutes of Health (NIH) “Prostatitis Collaborative”; Internationally known Urologist invited to speak at the 1st National Men’s Health Conference sponsored by Penn State.
Associate Member, Medical Physicist, Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL; Associate Professor, Department of Oncologic Sciences, College of Medicine, Department of Physics (Faculty Courtesy Appointment), University of South Florida, Tampa, FL.
is a privately held Biotechnology company, focused on isadult the licensing and commercialization of effective and high quality compound drugs, medical devices and treatments that already approved by the FDA.
Future Biomed Corp was founded by StemCell Lab Corp in 2009. In 2014, the management of StemCell Lab Corp decided to make Future Biomed an independent entity. Thus, as of 2014, Future Biomed is dissertationworld.com a Nevada Corporation.